期刊文献+

Metabolic surgery: A paradigm shift in type 2 diabetes management 被引量:2

Metabolic surgery: A paradigm shift in type 2 diabetes management
下载PDF
导出
摘要 Obesity and type 2 diabetes mellitus(T2DM) are major public health issues globally over the past few decades. Despite dietary interventions, lifestyle modifications and the availability of several pharmaceutical agents, management of T2 DM with obesity is a major challenge to clinicians. Metabolic surgery is emerging as a promising treatment option for the management of T2 DM in the obese population in recent years. Several observational studies and a few randomised controlled trials have shown clear benefits of various bariatric procedures in obese individuals in terms of improvement or remission of T2 DM and multiple other health benefits such as improvement of hypertension, obstructive sleep apnoea, osteoarthritis and non-alcoholic fatty liver disease. Uncertainties about the long-term implications of metabolic surgery such as relapse of T2 DM after initial remission, nutritional and psychosocial complications and the optimal body mass index for different ethnic groups exist. The article discusses the major paradigm shift in recent years in the management of T2 DM after the introduction of metabolic surgery. Obesity and type 2 diabetes mellitus (T2DM) are majorpublic health issues globally over the past few decades.Despite dietary interventions, lifestyle modificationsand the availability of several pharmaceutical agents,management of T2DM with obesity is a major challengeto clinicians. Metabolic surgery is emerging as apromising treatment option for the management ofT2DM in the obese population in recent years. Severalobservational studies and a few randomised controlledtrials have shown clear benefits of various bariatricprocedures in obese individuals in terms of improvementor remission of T2DM and multiple other health benefitssuch as improvement of hypertension, obstructive sleepapnoea, osteoarthritis and non-alcoholic fatty liverdisease. Uncertainties about the long-term implicationsof metabolic surgery such as relapse of T2DM after initialremission, nutritional and psychosocial complications andthe optimal body mass index for different ethnic groupsexist. The article discusses the major paradigm shiftin recent years in the management of T2DM after theintroduction of metabolic surgery.
出处 《World Journal of Diabetes》 SCIE CAS 2015年第8期990-998,共9页 世界糖尿病杂志(英文版)(电子版)
关键词 METABOLIC SURGERY BARIATRIC procedures Type 2 DIABETES MELLITUS BODY mass index Diabetesremission Metabolic surgery Bariatric procedures Type 2 diabetes mellitus Body mass index Diabetes remission
  • 相关文献

参考文献55

  • 1World Health Organization. Obesity and overweight. 2015.[assessed 2015 March 8]. Available from: URL: http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
  • 2Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence ofchildhood and adult obesity in the United States, 2011-2012. JAMA2014; 311: 806-814 [PMID: 24570244 DOI: 10.1001/jama.2014.732].
  • 3International Diabetes Federation. IDF Diabetes Atlas Update2014. [assessed 2015 March 8]. Available from: URL: http://www.idf.org/diabetesatlas/5e/Update2014.
  • 4Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, ColditzGA. The effectiveness and risks of bariatric surgery: an updatedsystematic review and meta-analysis, 2003-2012. JAMA Surg 2014;149: 275-287 [PMID: 24352617 DOI: 10.1001/jamasurg.2013].
  • 5Skroubis G, Kouri N, Mead N, Kalfarentzos F. Long-term resultsof a prospective comparison of Roux-en-Y gastric bypass versus avariant of biliopancreatic diversion in a non-superobese population(BMI 35-50 kg/m(2)). Obes Surg 2014; 24: 197-204 [PMID:24105406 DOI: 10.1007/s11695-013-1081-1].
  • 6Maleckas A, Venclauskas L, Wallenius V, L-nroth H, F-ndriks L.Surgery in the treatment of type 2 diabetes mellitus. Scand J Surg2015; 104: 40-47 [PMID: 25623915 DOI: 10.1177/1457496914561140].
  • 7Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A,Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, RubinoF. Bariatric surgery versus conventional medical therapy for type 2diabetes. N Engl J Med 2012; 366: 1577-1585 [PMID: 22449317DOI: 10.1056/NEJMoa1200111].
  • 8Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM,Skinner S, Proietto J, Bailey M, Anderson M. Adjustable gastricbanding and conventional therapy for type 2 diabetes: a randomizedcontrolled trial. JAMA 2008; 299: 316-323 [PMID: 18212316 DOI:10.1001/jama.299.3.316].
  • 9Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP,Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL. Bariatricsurgery versus intensive medical therapy in obese patients withdiabetes. N Engl J Med 2012; 366: 1567-1576 [PMID: 22449319DOI: 10.1056/NEJMoa1200225].
  • 10Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet WB,Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW,Ahmed L, Vella A, Chuang LM, Bessler M, Sarr MG, Swain JM,Laqua P, Jensen MD, Bantle JP. Roux-en-Y gastric bypass vsintensive medical management for the control of type 2 diabetes,hypertension, and hyperlipidemia: the Diabetes Surgery Studyrandomized clinical trial. JAMA 2013; 309: 2240-2249 [PMID:23736733 DOI: 10.1001/jama.2013.5835].

同被引文献3

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部